🇺🇸 FDA
Patent

US 9801865

Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation

granted A61KA61K31/4439A61K51/0455

Quick answer

US patent 9801865 (Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation) held by The United States of America as represented by the Department of Veteran Affairs expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Department of Veteran Affairs
Grant date
Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/4439, A61K51/0455, A61P, A61P25/26